|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020971,
umls-concept:C0026336,
umls-concept:C0037354,
umls-concept:C0042210,
umls-concept:C0042216,
umls-concept:C0086418,
umls-concept:C0205208,
umls-concept:C0205349,
umls-concept:C0439858,
umls-concept:C0591833,
umls-concept:C1545588,
umls-concept:C1999230
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-12-17
|
|
pubmed:abstractText |
Decades after the cessation of smallpox vaccination, the potential of the deliberate release of pathogenic orthopoxviruses has forced a reconsideration of using these extremely efficient human vaccines. Scenarios of sudden biothreats have prompted demand for rapidly protective vaccination. However, the feasibility of short-term vaccination (i.e., vaccination shortly before exposure) with vaccinia virus (VACV) is uncertain.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
pubmed-author:ErezNoamN,
pubmed-author:HanschmannKay-MartinKM,
pubmed-author:IsraelyTomerT,
pubmed-author:KalinkeUlrichU,
pubmed-author:KatzLiorL,
pubmed-author:LöwerJohannesJ,
pubmed-author:LevinReuvenR,
pubmed-author:LustigShlomoS,
pubmed-author:MelamedSharonS,
pubmed-author:ParanNirN,
pubmed-author:PreussThomasT,
pubmed-author:SchwantesAstridA,
pubmed-author:ShaffermanAvigdorA,
pubmed-author:SuezerYaseminY,
pubmed-author:SutterGerdG,
pubmed-author:VelanBaruchB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
199
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
39-48
|
|
pubmed:meshHeading |
pubmed-meshheading:19012492-Animals,
pubmed-meshheading:19012492-Cell Line,
pubmed-meshheading:19012492-Cercopithecus aethiops,
pubmed-meshheading:19012492-Cricetinae,
pubmed-meshheading:19012492-Disease Models, Animal,
pubmed-meshheading:19012492-Disease Progression,
pubmed-meshheading:19012492-Environmental Exposure,
pubmed-meshheading:19012492-HeLa Cells,
pubmed-meshheading:19012492-Humans,
pubmed-meshheading:19012492-Mice,
pubmed-meshheading:19012492-Respiratory Tract Infections,
pubmed-meshheading:19012492-Smallpox,
pubmed-meshheading:19012492-Smallpox Vaccine,
pubmed-meshheading:19012492-Vaccinia virus,
pubmed-meshheading:19012492-Vero Cells,
pubmed-meshheading:19012492-Viral Load
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
|
|
pubmed:affiliation |
Israel Institute for Biological Research, Ness-Ziona, Israel.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
